AI-powered drug developer Metis TechBio leads group that includes developers of autonomous driving technology and industrial robots.

Sixth batch under investment-attraction initiative to also feature Boehringer Ingelheim, Hengrui and HAYA, with DiDi and AutoFlight joining transport push.

Sixth batch under OASES initiative also features Boehringer Ingelheim, Hengrui and Haya, with Didi and AutoFlight joining transport push.

AI-powered drug developer Metis TechBio leads group that includes developers of autonomous driving technology and industrial robots.